Benchmark Holdings Regulatory News (BMK)

1 August 2022

Benchmark Holdings plc

("Benchmark" or the "Company")

Notice of Q3 Results

Webcast for analysts and institutional investors

Equity Development webcast for retail investors

Benchmark Holdings plc (AIM: BMK), the aquaculture health, advanced nutrition, and genetics business, will announce its Q3 results for the three month period ended 30 June 2022, on Thursday 25th August 2022. 

Webcast for analysts and institutional investors at 9am UK time

Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host a webcast for analysts and institutional investors on that day at 09:00am UK time. To register your interest, please contact benchmark@mhpc.com.

Equity Development webcast for retail investors at 12:00pm UK time

Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host a separate webcast for retail investors and wealth managers at 12.00pm UK time. The webcast is open to all existing and potential shareholders. Questions can be submitted during the presentation which will be addressed at the end.

To register please visit: https://www.equitydevelopment.co.uk/news-and-events/benchmark-q3results-presentation-aug25

Enquiries

About Benchmark

Benchmark is a market leading aquaculture biotechnology company. Benchmark's mission is to drive sustainability in aquaculture by delivering products and solutions in genetics, advanced nutrition and health which improve yield, growth and animal health and welfare.

Through a global footprint in 26 countries and a broad portfolio of products and solutions, Benchmark addresses the major aquaculture species - salmon, shrimp, sea bass and bream, and tilapia, in all the aquaculture regions around the world. Find out more at www.benchmarkplc.com